Symbol="OCUP"
AssetType="Common Stock"
Name="Ocuphire Pharma Inc"
Description="Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of various eye disorders. The company is headquartered in Farmington Hills, Michigan."
CIK="1228627"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="15245 SHADY GROVE ROAD, SUITE 455, ROCKVILLE, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="84018000"
EBITDA="18607000"
PERatio="4.359"
PEGRatio="None"
BookValue="1.969"
DividendPerShare="0"
DividendYield="0"
EPS="0.92"
RevenuePerShareTTM="2.035"
ProfitMargin="0.449"
OperatingMarginTTM="0.447"
ReturnOnAssetsTTM="0.353"
ReturnOnEquityTTM="0.639"
RevenueTTM="41599000"
GrossProfitTTM="-14584000"
DilutedEPSTTM="0.92"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="20.2"
TrailingPE="4.359"
ForwardPE="-"
PriceToSalesRatioTTM="92.17"
PriceToBookRatio="5.4"
EVToRevenue="52.97"
EVToEBITDA="-2.01"
Beta="0.101"
num_52WeekHigh="6.6"
num_52WeekLow="1.88"
num_50DayMovingAverage="3.984"
num_200DayMovingAverage="3.78"
SharesOutstanding="20952200"
DividendDate="2020-11-06"
ExDividendDate="None"
symbol="OCUP"
open="4.10"
high="4.14"
low="4.01"
price="4.01"
volume="68691.00"
latest_trading_day="2023-08-04"
previous_close="4.10"
change="-0.09"
change_percent="-2.1951%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="32"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="68"
Volume_recent_avg="295896"
Change_recent_avg="-0.01"
Delta_recent_avg="0.34"
Variance_recent_avg="0.17"
Change_ratio_recent_avg="-0.26"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="68"
Aroon_momentum_negative="32"
image_negative_thumbnail_id_1="133"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0043.jpeg"
image_negative_thumbnail_id_2="1100"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0133.jpeg"
image_neutral_thumbnail_id_1="556"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_neutral_thumbnail_id_2="572"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_positive_thumbnail_id_1="964"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0126.jpeg"
image_positive_thumbnail_id_2="962"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0124.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
